、、tv。。“、、、。、。。、t。tv。≥、”、、、、。、。、。、。、t、t。vtt、·。、。。“”。。、、、。、·、、、v、vwt。。tv、、、ttyvtt
20202202
182
4.2
[1]NeumannM.Eidence-based(S3)GuidelinesforDiagnosicsand
[20]
60
reamentofenouslegulcers-AnseroDrBerolini[J].JEurAcad
30DermaolVenereol,2017,31(9):e386
[2]ThakralGaura,LaFontaineJaier,KimPaul,eal.Treamentoptions
forenouslegulcers:effecienessofascularsurger,
bioengineeredissue,andelecricalsimulaion[J].AdvSkinWound
[21]Care,2015,28(4):164-172
[3],,.[J].,
2019,35(8):38-39
[4],,,.[J].
,2019,34(4):723-726
[5].
[D].:,2018
[6].
[22]
[D].:,2019
[7],,,.
[J].,2016,11(8):1113-1116
25%
[8].[A].
.2017[C].
4.3
:
[23]
,2017.1
[9],.[J].
,2017,12(12):1670-1672,1730
8
[10],.[J].
[24]
,2014,32(6):27-28
[11],,.
[J].,2017,12(1):130-133
[12],,,.[J].
[25]
,2019,43(1):72-74
[13],,.
[J].,2019,21(11):138-141
[14],,,.
4.4
[J].,2019,41(23):3623-3626
[15],,,.40
[J].,2019,28(8):99-101
[16],.[J].
[26]
,2014,32(4):7-9
[17],,.56[J].
,2017,33(1):94-96
[27]
16.6%
[18],.30[J].,2017,48
(2):39-41
[19],.
91.43%
32[J].,2016,14(11):80-82
[20].[D].:,
2018
[21],,,.
[28]
[J].,2017,20(33):4173-4177
[22],,,.
[J].,2017,51(7):60-62
[23].[D].:
,2017
[24],,.34
5
[J].,2017,26(14):127-128
[25].[D].:
,2017
[26].[J].,2017,26
(22):117-118
[27],.
[J].,2017,39(2):284-286
[28].
[D].:,2019
2019-11-20 |
|
